trial · primary record
ICP-B381
Advanced Solid Tumor
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 348 |
| Primary completion | 2028-07 |
| Primary endpoint | The type, severity (assessed according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 6.0 [NCI-CTCAE V6.0]), relationship to the investigational product, and incidence rate of adverse event (AE) and serious advers |
| Registry ID | NCT07901413 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:59.785Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07901413
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.